Govt cautions pharma cos against surrogate ads for promoting GLP-1 drugs

Weight loss drug risks: The government has warned of strict regulatory action against those found using surrogate advertising to promote GLP-1 drugs. "A detailed advisory on the use of GLP-1 drugs is expected to be released in the next few days," sources told ET.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9AnrLdw
via IFTTT

Read More

Decoding the antibiotic resistance crisis: How everyday habits can save our strongest medicines

Antibiotics are losing their power as germs grow stronger, a crisis fueled by everyday misuse. Experts urge parents to rethink treating minor ailments and fevers without medical advice. Preventing infections through simple hygiene practices like handwashing and sanitizing surfaces, summarized by the S.H.A.K.E. formula, is crucial to preserving these life-saving medicines for future generations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3diYcxA
via IFTTT

Read More

Raw nerve: Drugs may get costlier as prices of ingredients surge 30%

India's medicine prices are poised for a sharp increase due to a 30% surge in raw material costs, driven by container ship scarcity following the Iran war. This scarcity is hindering the movement of crucial ingredients from China, impacting local manufacturing and potentially forcing producers to pass on higher expenses to consumers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tk2Gyhv
via IFTTT

Read More

India's exports of active pharma ingredients at Rs 41,500 cr surpassed imports in FY25

With API exports hitting an impressive Rs 41,500 crore last fiscal year, India has outperformed its imports of Rs 39,215 crore. The government is pushing for a self-reliant economy via the Production Linked Incentive scheme, strategically aimed at cutting down import connections, notably with China.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qGlBJYv
via IFTTT

Read More

Pharma exporters seek freight sops and logistical support as costs rise

As tensions in West Asia escalate, Indian pharmaceutical exporters are grappling with surging costs. In response, Pharmexcil is advocating for government interventions, including freight subsidies and enhanced logistical support. Meanwhile, companies are pivoting towards alternative shipping routes and ramping up their buffer stocks in anticipation of potential disruptions.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HAW7DLB
via IFTTT

Read More

Looking beyond seasonal sniffles: Protecting children's immunity from climate instability

Climate change is disrupting traditional illness patterns, affecting children's health. Savlon Swasth India Mission promotes proactive hygiene with the S.H.A.K.E. formula. This strategy encourages sanitizing, handwashing, doctor consultations, wound care, and nutritious meals. These habits build resilience against unexpected illnesses. The mission has positively impacted millions of children through hygiene education programs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EbVX8jG
via IFTTT

Read More

Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDA

Cipla USA is recalling over 400 cartons of its generic anti-cancer drug Nilotinib Capsules (150 mg and 200 mg) due to a manufacturing issue, the US Food and Drug Administration has said. The recall affects specific batches distributed in the United States.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zEldipu
via IFTTT

Read More